$BHC
Bausch Health Companies Inc. Stock $bhc

$bhc Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000088559021000055 Filed on November 02, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$2.196B	$2.111B	$2.138B
YoY Change	-0.77%	-1.26%	-3.21%
Cost Of Revenue	$626.0M	$582.0M	$590.0M
YoY Change	-2.95%	-1.36%	1.03%
Gross Profit	$1.570B	$1.529B	$1.548B
YoY Change	0.13%	-1.23%	-4.74%
Gross Profit Margin	71.49%	72.43%	72.4%
Selling, General & Admin	$680.0M	$653.0M	$572.0M
YoY Change	6.92%	14.16%	-11.73%
% of Gross Profit	43.31%	42.71%	36.95%
Research & Development	$117.0M	$121.0M	$103.0M
YoY Change	-1.68%	17.48%	-16.26%
% of Gross Profit	7.45%	7.91%	6.65%
Depreciation & Amortization	$363.0M	$382.0M	$436.0M
YoY Change	-15.19%	-12.39%	-16.15%
% of Gross Profit	23.12%	24.98%	28.17%
Operating Expenses	$1.117B	$774.0M	$675.0M
YoY Change	-1.85%	14.67%	-12.45%
Operating Profit	$453.0M	$574.0M	$460.0M
YoY Change	-9160.0%	24.78%	39.82%
Interest Expense	-$346.0M	-$346.0M	-$385.0M
YoY Change	-9.19%	-10.13%	-2.53%
% of Operating Profit	-76.38%	-60.28%	-83.7%
Other Income/Expense, Net		$183.0M	-$18.00M
YoY Change		-1116.67%	80.0%
Pretax Income	$21.00M	$216.0M	$75.00M
YoY Change	-105.33%	188.0%	-213.64%
Income Tax	-$51.00M	$25.00M	$5.000M
% Of Pretax Income	-242.86%	11.57%	6.67%
Net Earnings	$69.00M	$188.0M	$71.00M
YoY Change	-145.1%	164.79%	-247.92%
Net Earnings / Revenue	3.14%	8.91%	3.32%
Basic Earnings Per Share		$0.52	$0.20
Diluted Earnings Per Share	$191.6K	$0.52	$0.20
COMMON SHARES
Basic Shares Outstanding	359.3M shares	359.6M shares	355.6M shares
Diluted Shares Outstanding		364.0M shares	357.8M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$582.0M	$690.0M	$977.0M
YoY Change	-3.8%	-29.38%	18.42%
Cash & Equivalents	$582.0M	$690.0M	$977.0M
Short-Term Investments
Other Short-Term Assets	$2.257B	$1.846B	$1.737B
YoY Change	9.24%	6.28%	174.41%
Inventory	$993.0M	$1.058B	$1.224B
Prepaid Expenses
Receivables	$1.775B	$1.730B	$1.733B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.607B	$5.324B	$5.671B
YoY Change	4.96%	-6.12%	31.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.598B	$1.584B	$1.550B
YoY Change	1.98%	2.19%	11.51%
Goodwill	$12.46B	$12.48B	$13.16B
YoY Change	-4.5%	-5.19%	0.83%
Intangibles	$6.948B	$7.258B	$8.923B
YoY Change	-17.73%	-18.66%	-16.22%
Long-Term Investments
YoY Change
Other Assets	$340.0M	$343.0M	$345.0M
YoY Change	-48.8%	-0.58%	-14.18%
Total Long-Term Assets	$23.60B	$23.93B	$25.89B
YoY Change	-8.75%	-7.58%	-5.38%
TOTAL ASSETS
Total Short-Term Assets	$5.607B	$5.324B	$5.671B
Total Long-Term Assets	$23.60B	$23.93B	$25.89B
Total Assets	$29.20B	$29.25B	$31.56B
YoY Change	-6.4%	-7.32%	-0.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$407.0M	$455.0M	$379.0M
YoY Change	20.77%	20.05%	-13.27%
Accrued Expenses	$4.791B	$4.982B	$4.353B
YoY Change	4.7%	14.45%	36.12%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$5.198B	$5.437B	$4.732B
YoY Change	5.8%	14.9%	26.69%
LONG-TERM LIABILITIES
Long-Term Debt	$22.65B	$22.36B	$24.34B
YoY Change	-5.31%	-8.15%	3.74%
Other Long-Term Liabilities	$653.0M	$872.0M	$907.0M
YoY Change	-35.47%	-3.86%	19.34%
Total Long-Term Liabilities	$23.31B	$23.23B	$25.25B
YoY Change	-6.54%	-8.0%	4.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.198B	$5.437B	$4.732B
Total Long-Term Liabilities	$23.31B	$23.23B	$25.25B
Total Liabilities	$29.24B	$29.39B	$30.91B
YoY Change	-4.44%	-4.92%	6.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.961B	-$9.030B	-$7.860B
YoY Change	11.83%	14.89%	32.41%
Common Stock	$10.78B	$10.75B	$10.65B
YoY Change	0.92%	0.89%	0.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$106.0M	-$204.0M	$587.0M
YoY Change
Total Liabilities & Shareholders Equity	$29.20B	$29.25B	$31.56B
YoY Change	-6.4%	-7.32%	-0.33%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	$69.00M	$188.0M	$71.00M
YoY Change	-145.1%	164.79%	-247.92%
Depreciation, Depletion And Amortization	$363.0M	$382.0M	$436.0M
YoY Change	-15.19%	-12.39%	-16.15%
Cash From Operating Activities	$24.00M	$564.0M	$256.0M
YoY Change	-93.91%	120.31%	-50.29%
INVESTING ACTIVITIES
Capital Expenditures	-$83.00M	-$68.00M	-$82.00M
YoY Change	-1.19%	-17.07%	-1.2%
Acquisitions
YoY Change
Other Investing Activities	$3.000M	$656.0M	$12.00M
YoY Change		5366.67%	20.0%
Cash From Investing Activities	-$80.00M	$588.0M	-$70.00M
YoY Change	-4.76%	-940.0%	-4.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	275.0M	-1.157B	-117.0M
YoY Change	-154.67%	888.89%	-75.32%
NET CHANGE
Cash From Operating Activities	24.00M	564.0M	$256.0M
Cash From Investing Activities	-80.00M	588.0M	-70.00M
Cash From Financing Activities	275.0M	-1.157B	-117.0M
Net Change In Cash	219.0M	-5.000M	$256.0M
YoY Change	-44.42%	-101.95%	-50.29%
FREE CASH FLOW
Cash From Operating Activities	$24.00M	$564.0M	$256.0M
Capital Expenditures	-$83.00M	-$68.00M	-$82.00M
Free Cash Flow	$107.0M	$632.0M	$338.0M
YoY Change	-77.62%	86.98%	-43.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000885590
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
	bhc	Proposed Initial Public Offering Subsequent To Related Entity Initial Public Offering If Circumstances Met Period ProposedInitialPublicOfferingSubsequentToRelatedEntityInitialPublicOfferingIfCircumstancesMetPeriod	P30D
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-14956
	dei	Entity Registrant Name EntityRegistrantName	Bausch Health Companies Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
	dei	Entity Address Country EntityAddressCountry	CA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0448205
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2150 St. Elzéar Blvd. West
	dei	Entity Address City Or Town EntityAddressCityOrTown	Laval
	dei	Entity Address State Or Province EntityAddressStateOrProvince	QC
	dei	Entity Address Country EntityAddressCountry	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	H7L 4A8
	dei	City Area Code CityAreaCode	514
	dei	Local Phone Number LocalPhoneNumber	744-6792
	dei	Security12b Title Security12bTitle	Common Shares, No Par Value
	dei	Trading Symbol TradingSymbol	BHC
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	359330757	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	690000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	605000000	USD
CY2021Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	1214000000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1211000000	USD
CY2021Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	1730000000	USD
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1577000000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	1058000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1094000000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	632000000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	855000000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	5324000000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	5342000000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1584000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1567000000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7258000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8445000000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	12477000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	13044000000	USD
CY2021Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2266000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2137000000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	343000000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	664000000	USD
CY2021Q3	us-gaap	Assets Assets	29252000000	USD
CY2020Q4	us-gaap	Assets Assets	31199000000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	455000000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	337000000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4982000000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4576000000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5437000000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4913000000	USD
CY2021Q3	bhc	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	207000000	USD
CY2020Q4	bhc	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	216000000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	22358000000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	23925000000	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	513000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	528000000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	872000000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1012000000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	29387000000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	30594000000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	359154635	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	359154635	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	355422347	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	355422347	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	10312000000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	10227000000	USD
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	437000000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	454000000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9030000000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8013000000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1923000000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2133000000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-204000000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	535000000	USD
CY2021Q3	us-gaap	Minority Interest MinorityInterest	69000000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	70000000	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-135000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	605000000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29252000000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31199000000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2111000000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2138000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6238000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5814000000	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	653000000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	572000000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1944000000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1731000000	USD
CY2021Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	121000000	USD
CY2020Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	103000000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	348000000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	333000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	213000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	17000000	USD
CY2021Q3	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	338000000	USD
CY2020Q3	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	391000000	USD
	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1055000000	USD
	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1263000000	USD
CY2021Q3	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	0	USD
CY2020Q3	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	0	USD
	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	469000000	USD
	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	0	USD
CY2021Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	18000000	USD
CY2020Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2000000	USD
CY2021Q3	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	8000000	USD
CY2020Q3	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	2000000	USD
	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	29000000	USD
	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	13000000	USD
CY2021Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	183000000	USD
CY2020Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-18000000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-329000000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-172000000	USD
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	1537000000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	1678000000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	6155000000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	5133000000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	574000000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	460000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	83000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	681000000	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-12000000	USD
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6000000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	11000000	USD
CY2021Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	351000000	USD
CY2020Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	374000000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	1083000000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	1155000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-62000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-51000000	USD
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3000000	USD
CY2020Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-13000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	11000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-26000000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5000000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	216000000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	75000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1045000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-540000000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-36000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-133000000	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	191000000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	70000000	USD
	us-gaap	Profit Loss ProfitLoss	-1009000000	USD
	us-gaap	Profit Loss ProfitLoss	-407000000	USD
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3000000	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8000000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	188000000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	71000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1017000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-407000000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.84
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.15
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.84
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.15
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	359600000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	355600000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	358500000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	354700000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	364000000.0	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	357800000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	358500000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	354700000	shares
CY2021Q3	us-gaap	Profit Loss ProfitLoss	191000000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	70000000	USD
	us-gaap	Profit Loss ProfitLoss	-1009000000	USD
	us-gaap	Profit Loss ProfitLoss	-407000000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-80000000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	20000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-128000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-118000000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	1000000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	1000000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	1000000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	2000000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-81000000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	19000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-129000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-120000000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	110000000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	89000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1138000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-527000000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3000000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2000000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	9000000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1000000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	107000000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	87000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1147000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-528000000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-611000000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6000000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33000000	USD
CY2021Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3000000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	340000000	USD
CY2021Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	10000000	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	191000000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-81000000	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-135000000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	546000000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27000000	USD
CY2020Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1000000	USD
CY2020Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	6000000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	70000000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	19000000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	655000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	605000000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	21000000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	95000000	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	48000000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	340000000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	10000000	USD
	us-gaap	Profit Loss ProfitLoss	-1009000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-129000000	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-135000000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1136000000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2000000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	81000000	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	30000000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	6000000	USD
	us-gaap	Profit Loss ProfitLoss	-407000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-120000000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	655000000	USD
	us-gaap	Profit Loss ProfitLoss	-1009000000	USD
	us-gaap	Profit Loss ProfitLoss	-407000000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1189000000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1397000000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	42000000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	45000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	213000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	17000000	USD
	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	469000000	USD
	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	0	USD
	bhc	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	8000000	USD
	bhc	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	26000000	USD
	bhc	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	51000000	USD
	bhc	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	52000000	USD
	bhc	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-137000000	USD
	bhc	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-213000000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2000000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1000000	USD
	bhc	Gain Loss Related To Litigation Settlement Gross GainLossRelatedToLitigationSettlementGross	-534000000	USD
	bhc	Gain Loss Related To Litigation Settlement Gross GainLossRelatedToLitigationSettlementGross	-147000000	USD
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	144000000	USD
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	82000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	95000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	81000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-8000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-14000000	USD
	bhc	Derivative Gain Excluded Component DerivativeGainExcludedComponent	17000000	USD
	bhc	Derivative Gain Excluded Component DerivativeGainExcludedComponent	17000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-62000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-51000000	USD
	bhc	Payment For Contingent Consideration Liability Including Accretion Operating Activities PaymentForContingentConsiderationLiabilityIncludingAccretionOperatingActivities	16000000	USD
	bhc	Payment For Contingent Consideration Liability Including Accretion Operating Activities PaymentForContingentConsiderationLiabilityIncludingAccretionOperatingActivities	0	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	33000000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7000000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	177000000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-67000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	62000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	178000000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-37000000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-11000000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	291000000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-286000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1402000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	717000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	191000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	222000000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	9000000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3000000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	14000000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	3000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	11000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	7000000	USD
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	669000000	USD
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	21000000	USD
	bhc	Interest Settlement On Cross Currency Swaps InterestSettlementOnCrossCurrencySwaps	23000000	USD
	bhc	Interest Settlement On Cross Currency Swaps InterestSettlementOnCrossCurrencySwaps	23000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	489000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-177000000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1576000000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1476000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3200000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3162000000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1000000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	30000000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	48000000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	39000000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	1000000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	48000000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	30000000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	77000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	9000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-6000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1788000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1791000000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-15000000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5000000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	88000000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1256000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1816000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3244000000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1904000000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1988000000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	690000000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	977000000	USD
CY2021Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	1214000000	USD
CY2020Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	1011000000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1904000000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1988000000	USD
	us-gaap	Nature Of Operations NatureOfOperations	DESCRIPTION OF BUSINESS Bausch Health Companies Inc. (the “Company” or "Bausch Health") is a multinational, specialty pharmaceutical and medical device company that develops, manufactures and markets, primarily in the therapeutic areas of eye health, gastroenterology ("GI") and dermatology, a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (“OTC”) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices) which are marketed directly or indirectly in approximately 100 countries.
CY2021Q3	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	100	country
CY2021Q3	bhc	Proposed Business Separation And Initial Public Offering Number Of Companies Established ProposedBusinessSeparationAndInitialPublicOfferingNumberOfCompaniesEstablished	3	company
CY2021Q3	bhc	Proposed Business Separation And Initial Public Offering Number Of Companies Established ProposedBusinessSeparationAndInitialPublicOfferingNumberOfCompaniesEstablished	3	company
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the unaudited Consolidated Financial Statements, management is required to make estimates and assumptions. This includes estimates and assumptions regarding the nature, timing and extent of the impacts that the COVID-19 pandemic will have on its operations and cash flows. The estimates and assumptions used by the Company affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited Consolidated Financial Statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates and the differences could be material. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s results of operations and financial position could be materially impacted.</span></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior year amounts to conform to the current year presentation.</span></div>
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1813000000	USD
	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	4062000000	USD
	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	3924000000	USD
CY2021Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1951000000	USD
CY2019Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	2050000000	USD
	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	3697000000	USD
	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	3845000000	USD
CY2020Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1902000000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	39000000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	48000000	USD
	bhc	Accounts Receivable Effect Of Retrospective Application Of Accounting Standards Update AccountsReceivableEffectOfRetrospectiveApplicationOfAccountingStandardsUpdate	0	USD
	bhc	Accounts Receivable Effect Of Retrospective Application Of Accounting Standards Update AccountsReceivableEffectOfRetrospectiveApplicationOfAccountingStandardsUpdate	1000000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1000000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7000000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	3000000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	3000000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	2000000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	1000000	USD
	bhc	Accounts Receivable Allowance For Foreign Exchange And Other AccountsReceivableAllowanceForForeignExchangeAndOther	0	USD
	bhc	Accounts Receivable Allowance For Foreign Exchange And Other AccountsReceivableAllowanceForForeignExchangeAndOther	1000000	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	37000000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	53000000	USD
CY2021Q2	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	10000000	USD
CY2021Q3	bhc	Additional Payments To Acquire Equity Securities Fvni Expected AdditionalPaymentsToAcquireEquitySecuritiesFVNIExpected	0	USD
	bhc	Highly Liquid Investments Maturity Period HighlyLiquidInvestmentsMaturityPeriod	P3M
	us-gaap	Payments For Proceeds From Hedge Investing Activities PaymentsForProceedsFromHedgeInvestingActivities	23000000	USD
	us-gaap	Payments For Proceeds From Hedge Investing Activities PaymentsForProceedsFromHedgeInvestingActivities	23000000	USD
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	328000000	USD
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	316000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	8000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	26000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	93000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	30000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	1000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	0	USD
CY2021Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	244000000	USD
CY2020Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	312000000	USD
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	37000000	USD
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	37000000	USD
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	207000000	USD
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	275000000	USD
CY2021Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	282000000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	286000000	USD
CY2021Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	133000000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	143000000	USD
CY2021Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	643000000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	665000000	USD
CY2021Q3	us-gaap	Inventory Gross InventoryGross	1058000000	USD
CY2020Q4	us-gaap	Inventory Gross InventoryGross	1094000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25422000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19868000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5554000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25481000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	18741000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6740000000	USD
CY2021Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	27126000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19868000000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7258000000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	27186000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	18741000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8445000000	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	213000000	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	17000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	320000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1169000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1013000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	891000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	809000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	678000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	674000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5554000000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	13126000000	USD
CY2020	bhc	Goodwill Transfers Related To Sale Of Business Unit GoodwillTransfersRelatedToSaleOfBusinessUnit	18000000	USD
CY2020	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	217000000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-117000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	13044000000	USD
	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	469000000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	98000000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	12477000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6238000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5814000000	USD
	bhc	Increase Decrease In Year Over Year Revenue From Contract With Customer Excluding Assessed Tax IncreaseDecreaseInYearOverYearRevenueFromContractWithCustomerExcludingAssessedTax	424000000	USD
CY2020Q2	bhc	Increase Decrease In Year Over Year Revenue From Contract With Customer Excluding Assessed Tax Percentage IncreaseDecreaseInYearOverYearRevenueFromContractWithCustomerExcludingAssessedTaxPercentage	-0.23
CY2020Q3	bhc	Increase Decrease In Year Over Year Revenue From Contract With Customer Excluding Assessed Tax Percentage IncreaseDecreaseInYearOverYearRevenueFromContractWithCustomerExcludingAssessedTaxPercentage	-0.03
CY2020Q4	bhc	Increase Decrease In Year Over Year Revenue From Contract With Customer Excluding Assessed Tax Percentage IncreaseDecreaseInYearOverYearRevenueFromContractWithCustomerExcludingAssessedTaxPercentage	-0.01
CY2021Q1	us-gaap	Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount	0.40
CY2021Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q2	us-gaap	Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount	0.45
CY2021Q2	us-gaap	Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount	0.45
CY2021Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	4180000000	USD
CY2021Q3	bhc	Legalsettlementsandrelatedfees Legalsettlementsandrelatedfees	2061000000	USD
CY2020Q4	bhc	Legalsettlementsandrelatedfees Legalsettlementsandrelatedfees	1672000000	USD
CY2021Q3	bhc	Accrued Product Rebate Current AccruedProductRebateCurrent	964000000	USD
CY2020Q4	bhc	Accrued Product Rebate Current AccruedProductRebateCurrent	747000000	USD
CY2021Q3	bhc	Accrued Product Return Current AccruedProductReturnCurrent	502000000	USD
CY2020Q4	bhc	Accrued Product Return Current AccruedProductReturnCurrent	575000000	USD
CY2021Q3	us-gaap	Interest Payable Current InterestPayableCurrent	355000000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	341000000	USD
CY2021Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	308000000	USD
CY2020Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	316000000	USD
CY2021Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	111000000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	158000000	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	681000000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	767000000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4982000000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4576000000	USD
CY2021Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	22585000000	USD
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	22358000000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	24185000000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	23925000000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	22358000000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	23925000000	USD
	bhc	Debt Instrument Redemption Price Percentage Changein Control DebtInstrumentRedemptionPricePercentageChangeinControl	1.01
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-38000000	USD
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-27000000	USD
CY2021Q3	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0591
CY2020Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0602
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	9723000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	95000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	81000000	USD
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33000000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	27000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	95000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	81000000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1500000000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	11362000000	USD
CY2021Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	22585000000	USD
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	227000000	USD
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	22358000000	USD
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33000000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	27000000	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	143000000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M
CY2021Q3	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	114000000	USD
CY2020Q3	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	95000000	USD
	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	328000000	USD
	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	309000000	USD
CY2021Q3	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	7000000	USD
CY2020Q3	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	8000000	USD
	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	20000000	USD
	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	24000000	USD
CY2021Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	121000000	USD
CY2020Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	103000000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	348000000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	333000000	USD
CY2021Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	212000000	USD
CY2020Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-4000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-320000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-127000000	USD
CY2021Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	8000000	USD
CY2020Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2000000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	8000000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	26000000	USD
CY2021Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-21000000	USD
CY2020Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2000000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1000000	USD
CY2021Q3	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2020Q3	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	12000000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	3000000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	20000000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	183000000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-18000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-329000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-172000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-36000000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-34000000	USD
	bhc	Effective Income Tax Rate Reconciliation Discrete Items Amount EffectiveIncomeTaxRateReconciliationDiscreteItemsAmount	-2000000	USD
	bhc	Effective Income Tax Rate Reconciliation Legal Settlements Amount EffectiveIncomeTaxRateReconciliationLegalSettlementsAmount	-54000000	USD
	bhc	Effective Income Tax Rate Reconciliation Withholding Tax Intercompany Dividends Amount EffectiveIncomeTaxRateReconciliationWithholdingTaxIntercompanyDividendsAmount	46000000	USD
	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	11000000	USD
	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-8000000	USD
	bhc	Effective Income Tax Rate Reconciliation Expense Filing Tax Returns Amount EffectiveIncomeTaxRateReconciliationExpenseFilingTaxReturnsAmount	3000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-133000000	USD
	bhc	Effective Income Tax Rate Reconciliation Discrete Items Amount EffectiveIncomeTaxRateReconciliationDiscreteItemsAmount	-105000000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-63000000	USD
	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-36000000	USD
	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-10000000	USD
	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-7000000	USD
	bhc	Effective Income Tax Rate Reconciliation Expense Filing Tax Returns Amount EffectiveIncomeTaxRateReconciliationExpenseFilingTaxReturnsAmount	11000000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-28000000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2218000000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2252000000	USD
CY2021Q3	bhc	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	1117000000	USD
CY2020Q4	bhc	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	1025000000	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	53000000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	49000000	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	550000000	USD
CY2021Q3	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	194000000	USD
	us-gaap	Income Tax Examination Estimate Of Possible Loss IncomeTaxExaminationEstimateOfPossibleLoss	2100000000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	188000000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	71000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1017000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-407000000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	359600000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	355600000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	358500000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	354700000	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4400000	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2200000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	364000000.0	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	357800000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	358500000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	354700000	shares
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.84
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.15
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.84
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.15
CY2021Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	2061000000	USD
CY2021Q3	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	338000000	USD
CY2020Q3	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	391000000	USD
	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1055000000	USD
	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	1263000000	USD
CY2021Q3	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	0	USD
CY2020Q3	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	0	USD
	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	469000000	USD
	bhc	Goodwill Impairment Loss Not Included In Asset Impairment Charges GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges	0	USD
CY2021Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	18000000	USD
CY2020Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	213000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	17000000	USD
CY2021Q3	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	8000000	USD
CY2020Q3	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	2000000	USD
	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	29000000	USD
	bhc	Restructuring Charges And Initial Public Offering Costs RestructuringChargesAndInitialPublicOfferingCosts	13000000	USD
CY2021Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	183000000	USD
CY2020Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-18000000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-329000000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-172000000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	574000000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	460000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	83000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	681000000	USD
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6000000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	11000000	USD
CY2021Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	351000000	USD
CY2020Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	374000000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	1083000000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	1155000000	USD
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-12000000	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-62000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-51000000	USD
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3000000	USD
CY2020Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-13000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	11000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-26000000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	216000000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	75000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1045000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-540000000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2111000000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2138000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6238000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5814000000	USD
	bhc	Concentration Risk Number Of Products ConcentrationRiskNumberOfProducts	10	product
	bhc	Concentration Risk Number Of Products ConcentrationRiskNumberOfProducts	10	product
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2111000000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2138000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6238000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5814000000	USD

Files In Submission

Name	View Source	Status
0000885590-21-000055-index-headers.html	Edgar Link	pending
0000885590-21-000055-index.html	Edgar Link	pending
0000885590-21-000055.txt	Edgar Link	pending
0000885590-21-000055-xbrl.zip	Edgar Link	pending
bhc-20210930.htm	Edgar Link	pending
bhc-20210930.xsd	Edgar Link	pending
bhc-20210930_cal.xml	Edgar Link	unprocessable
bhc-20210930_def.xml	Edgar Link	unprocessable
bhc-20210930_htm.xml	Edgar Link	completed
bhc-20210930_lab.xml	Edgar Link	unprocessable
bhc-20210930_pre.xml	Edgar Link	unprocessable
exhibit101-formof2021share.htm	Edgar Link	pending
exhibit102-amendmenttohere.htm	Edgar Link	pending
exhibit311q32021.htm	Edgar Link	pending
exhibit312q32021.htm	Edgar Link	pending
exhibit321q32021.htm	Edgar Link	pending
exhibit322q32021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BHC
Bausch Health Companies Inc. Stock $bhc

2021 Q4 Form 10-Q Financial Statement

#000088559021000055 Filed on November 02, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC Bausch Health Companies Inc. Stock $bhc

2021 Q4 Form 10-Q Financial Statement

#000088559021000055 Filed on November 02, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC
Bausch Health Companies Inc. Stock $bhc